XML 31 R20.htm IDEA: XBRL DOCUMENT v3.19.1
Fair Value Measurements (Tables)
3 Months Ended
Mar. 31, 2019
Fair Value Disclosures [Abstract]  
Summary of Fair Value Measurements of Cash Equivalents, Available-for-Sale Marketable Securities and Free Share Asset/Liability

The fair value measurements of the Company’s cash equivalents, available-for-sale marketable securities and the free share asset/liability are identified at the following levels within the fair value hierarchy (in thousands):

 

 

 

March 31, 2019

 

 

 

Fair Value Measurements

 

 

 

Total

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

15,233

 

 

$

15,233

 

 

$

 

 

$

 

Commercial paper securities

 

 

4,990

 

 

 

 

 

 

4,990

 

 

 

 

Total

 

 

20,223

 

 

 

15,233

 

 

 

4,990

 

 

 

 

Marketable securities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Commercial paper securities

 

 

180,399

 

 

 

 

 

 

180,399

 

 

 

 

Corporate debt securities

 

 

70,948

 

 

 

 

 

 

70,948

 

 

 

 

U.S. government-sponsored entity debt securities

 

 

18,681

 

 

 

 

 

 

18,681

 

 

 

 

Total

 

 

270,028

 

 

 

 

 

 

270,028

 

 

 

 

Total cash equivalents and marketable securities

 

$

290,251

 

 

$

15,233

 

 

$

275,018

 

 

$

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Free shares asset

 

$

355

 

 

$

 

 

$

 

 

$

355

 

 

 

 

December 31, 2018

 

 

 

Fair Value Measurements

 

 

 

Total

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

103,291

 

 

$

103,291

 

 

$

 

 

$

 

Total

 

 

103,291

 

 

 

103,291

 

 

 

 

 

 

 

Marketable securities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Commercial paper securities

 

 

177,224

 

 

 

 

 

 

177,224

 

 

 

 

Corporate debt securities

 

 

63,870

 

 

 

 

 

 

63,870

 

 

 

 

U.S. government-sponsored entity debt securities

 

 

18,621

 

 

 

 

 

 

18,621

 

 

 

 

Total

 

 

259,715

 

 

 

 

 

 

259,715

 

 

 

 

Total cash equivalents and marketable securities

 

$

363,006

 

 

$

103,291

 

 

$

259,715

 

 

$

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Free shares liability

 

$

154

 

 

$

 

 

$

 

 

$

154

 

Total

 

$

154

 

 

$

 

 

$

 

 

$

154

 

 

Summary of Estimated Fair Value of Free Shares Valuation Assumptions The assumptions used in this simulation model are reviewed on a quarterly basis and adjusted, as needed. Subsequent changes in the fair value of the free shares are recorded in operating expenses in the condensed consolidated statement of operations.

 

Free Shares valuation assumptions:

 

March 31, 2019

 

 

December 31, 2018

 

Sangamo Stock Price (USD)

 

$

9.54

 

 

$

11.48

 

TxCell Stock Price (EUR)

 

$

2.36

 

 

$

2.58

 

EUR/ USD Exchange Rate

 

 

0.89

 

 

 

0.87

 

Estimated Correlation Sangamo and TxCell Stock Prices

 

 

50.0

%

 

 

 

Sangamo Stock Price (USD) Volatility Estimate

 

 

87.7

%

 

 

79.9

%

TxCell Stock Price (EUR) Volatility Estimate

 

 

82.8

%

 

 

8.6

%

EUR/ USD Exchange Rate Volatility Estimate

 

 

7.2

%

 

 

7.7

%

Risk Free Rate

 

Varies by expected exercise date

 

 

Varies by expected exercise date